Get the App

Back Stocks profile

Stock analysis tool for investors

Aarti Pharmalabs Ltd.

NSE: AARTIPHARM | BSE:543748

₹511.90 -0.70 (-0.14%) 1D

Pharmaceuticals & Biotechnology

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

508.00

Today’s High

518.40

52W low

320.30

52W High

567.00

Open Price

510.00

Prev. Close

438.0500

Volume

104743.00

Value

53617941.70

Fundamentals

Market Cap Cr

4639.10

Price to Earnings

23.80

Price to Book Value

3.00

Dividend Yield

0.40

PE to Growth

-0.70

Op Revenue TTM Cr

1831.91

Net Profit TTM Cr

194.52

Cash From Operating Activity Cr

263.00

Return on Equity %

12.41

EMA & SMA

Bullish Moving Averages

13

Bearish Moving Averages

3

5Day EMA

513.6

10Day EMA

508.4

12Day EMA

505.4

20Day EMA

495.3

26Day EMA

490.9

50Day EMA

485.4

100Day EMA

476.7

200Day EMA

446.4

5Day SMA

514.8

10Day SMA

516

20Day SMA

486.5

30Day SMA

474.6

50Day SMA

478.8

100Day SMA

494.3

150Day SMA

467.3

200Day SMA

445.4

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

03 May, 2024

42.1

Week

54.6

Month

54.2

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

512.75

PIVOT

First Resistance

517.50

Second Resistance

523.10

Third Resistance

527.85

First Support

507.15

Second Support

502.40

Third Support

496.80

Relative Strength Index

60.96

Money Flow Index

82.07

MACD

14.48

MACD Signal

11.46

Average True Range

17.63

Average Directional Index

32.2

Rate of Change (21)

14.07

Rate of Change (125)

33

Commodity Channel Index

58.2

Williams %R

-27.2

BETA

1 Month

-0.41

3 Month

1.4

1 Year

0.6

3 Year

PRICE CHANGE ANALYSIS

↓ -1.85%

1 Week

Low

High

505.7

525

↑ 12.48%

1 Month

Low

High

430

542.5

↓ -0.9%

3 Months

Low

High

399.55

566.95

↑ 30.75%

6 Months

Low

High

380.05

566.95

↑ 30.35%

1 Year

Low

High

320.3

566.95

Indicator Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Graph
Total Qtr Revenue cr 373.23 356.14 363.00 374.27 1138.26 405.74 373.15 367.21
Operating Expenses Qtr 284.76 282.33 281.40 297.48 905.44 324.24 294.44 296.49
Operating Profit Qtr 88.27 73.81 76.74 76.79 231.54 80.26 78.71 68.21
EBIDT Qtr Cr 88.47 73.81 81.60 76.79 232.82 81.50 78.71 70.72
Depreciation Qtr 16.94 16.32 15.44 14.25 41.52 14.55 12.41 12.44
Net Profit Qtr 48.19 41.81 47.63 39.99 131.73 45.93 47.25 44.88
Basic EPS Qtr 5.32 4.61 5.26 4.41 14.54 5.07 5.21 4.95
Indicator Mar 2023 Mar 2022 Mar 2021 Graph
Total Revenue Annual 1512.53 943.53 0.00
Operating Expenses Annual Cr 1202.91 761.24 0.00
Operating Profit Annual 308.34 179.79 -0.00
Operating Profit Margin Annual % 20.39 19.05 -
Total Expenses Annual Cr 1279.17 809.81 0.00
EBIDT Annual Cr 309.62 182.30 -0.00
EBIDT Annual margin % 20.47 19.32 -
Depreciation 55.77 37.23 0.00
PAT Before ExtraOrdinary Items Annual Cr 171.73 106.73 -0.00
Net Profit Annual 171.73 106.73 -0.00
Basic EPS Annual 18.95 11.78 -0.18
Indicator Mar 2023 Mar 2022 Mar 2021 Graph
Total ShareHolders Funds Annual 1438.58 1284.28 0.23
Minority Interest Liability Annual Cr - - -
Total Non Current Liabilities Annual Cr 69.38 60.88 0.02
Total Current Liabilities Annual Cr 455.31 481.67 0.00
Total Capital Plus Liabilities Annual Cr 1963.27 1826.83 0.25
Fixed Assets Annual 950.30 888.48 0.00
Total Non Current Assets Annual 1004.30 936.56 0.00
Total Current Assets Annual 958.98 890.27 0.25
Total Assets Annual 1963.27 1826.83 0.25
Contingent Liabilities plus Commitments Annual Cr 20.86 19.40 0.00
Indicator Mar 2023 Mar 2022 Mar 2021 Graph
Cash from Operating Activity Annual 228.69 -64.84 0.00
Cash from Investing Activity Annual -115.55 -133.54 0.00
Cash from Financing Annual Activity -156.53 254.63 0.00
Net Cash Flow Annual -43.39 56.25 0.00
Indicator Mar 2023 Mar 2022 Mar 2021 Graph
Book Value Per Share Annual 158.74 281.87 9.07
ROE Annual % 11.93 8.31 -2.02
ROCE Annual % 16.83 10.78 -1.87
Total Debt to Total Equity Annual 0.14 0.25 0.00
EBDIT Annual Margin % 20.48 19.37 0.00
Indicator Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Graph
Total Qtr Revenue cr 450.08 440.78 458.84 485.80 1461.74 532.44 457.39 462.82
Operating Expenses Qtr 353.01 351.80 373.49 405.06 1198.11 441.40 371.32 384.68
Operating Profit Qtr 95.67 88.00 84.87 80.00 262.06 89.77 86.05 75.62
EBIDT Qtr Cr 97.07 88.98 85.35 80.74 263.64 91.04 86.07 78.14
Depreciation Qtr 18.77 18.14 17.20 15.95 46.59 16.57 13.77 14.07
Net Profit Qtr 52.76 51.80 47.09 42.87 150.62 51.09 51.84 48.87
Basic EPS Qtr 5.82 5.72 5.20 4.73 16.62 5.64 5.72 5.39
Indicator Mar 2023 Mar 2022 Graph
Total Revenue Annual 1947.55 1202.46
Operating Expenses Annual Cr 1603.18 993.00
Operating Profit Annual 342.05 206.94
Operating Profit Margin Annual % 17.56 17.21
Total Expenses Annual Cr 1686.78 1047.08
EBIDT Annual Cr 344.37 209.46
EBIDT Annual margin % 17.68 17.42
Depreciation 62.54 42.12
PAT Before ExtraOrdinary Items Annual Cr 193.49 122.25
Net Profit Annual 193.49 122.25
Basic EPS Annual 21.35 13.49
Indicator Mar 2023 Mar 2022 Graph
Total ShareHolders Funds Annual 1558.49 1386.48
Minority Interest Liability Annual Cr 0.00 0.00
Total Non Current Liabilities Annual Cr 80.87 72.76
Total Current Liabilities Annual Cr 591.57 580.66
Total Capital Plus Liabilities Annual Cr 2230.93 2039.90
Fixed Assets Annual 1025.93 967.68
Total Non Current Assets Annual 1075.17 1011.75
Total Current Assets Annual 1155.76 1028.15
Total Assets Annual 2230.93 2039.90
Contingent Liabilities plus Commitments Annual Cr 20.86 397.48
Indicator Mar 2023 Mar 2022 Graph
Cash from Operating Activity Annual 263.00 -43.70
Cash from Investing Activity Annual -157.80 -138.74
Cash from Financing Annual Activity -163.47 260.38
Net Cash Flow Annual -58.28 77.94
Indicator Mar 2023 Mar 2022 Graph
Book Value Per Share Annual 171.97 304.30
ROE Annual % 12.41 8.81
ROCE Annual % 17.19 11.46
Total Debt to Total Equity Annual 0.14 0.24
EBDIT Annual Margin % 17.70 17.45
Name Holding Percent Holding Id Pledged % Locked %
Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Flexi Cap Fund 1.05 74517095 - -
Baron Emerging Markets Fund 1.01 74517103 - -
Name Holding Percent Holding Id Pledged % Locked %
Rashesh Chandrakant Gogri 4.23 74517038 0 0
Renil Rajendra Gogri 3.08 74517040 0 0
Mirik Rajendra Gogri 3.08 74517039 0 0
Jaya Chandrakant Gogri 2.97 74517041 0 0
Hetal Gogri Gala 2.89 74517042 0 0
Sarla Shantilal Shah 2.69 74517043 0 0
Rajendra Vallabhaji Gogri 1.57 74517044 0 0
Nehal Garewal 1.24 74517045 0 0
Nikhil Parimal Desai 0.85 74517046 0 0
Aarnav Rashesh Gogri 0.61 74517047 0 0
Aashay Rashesh Gogri 0.61 74517048 0 0
Manisha Rashesh Gogri 0.61 74517049 0 0
Bhavna Shah Lalka 0.57 74517050 0 0
Arti Rajendra Gogri 0.52 74517051 0 0
Anushakti Enterprise Private Limited 3.28 74517068 0 0
LABDHI BUSINESS TRUST (Saswat Trusteeship Private Limited) 3.14 74517069 0 0
ORCHID FAMILY TRUST (Relacion Trusteeship Services Private Limited) 1.82 74517070 0 0
TULIP FAMILY TRUST (Gloire Trusteeship Services Private Limited) 1.82 74517077 0 0
Safechem Enterprises Private Limited 1.61 74517078 0 0
MANOMAYA BUSINESS TRUST (Alabhya Trusteeship Private Limited) 1.44 74517079 0 0
Heena Family Private Trust (Barclays Wealth Trustees India Private Limited) 0.92 74517080 0 0
Bhavna Family Private Trust (Barclays Wealth Trustees India Pvt Ltd) 0.89 74517081 0 0
JASMINE FAMILY TRUST (Relacion Trusteeship Services Private Limited) 0.76 74517082 0 0
Alchemie Financial Services Limited 0.74 74517083 0 0
LOTUS FAMILY TRUST (Gloire Trusteeship Services Private Limited) 0.69 74517084 0 0
Name Holding Percent Holding Id
Aditya Birla Sun Life Trustee Private Limited A/C Aditya Birla Sun Life Flexi Cap Fund 1.05 74517095
Ntasain Discovery Master Fund 2.04 74517105
Morgan Stanley Investment Funds Emerging Leaders Equity Fund 1.08 74517102
Baron Emerging Markets Fund 1.01 74517103
Life Insurance Corporation Of India 6.26 74517097
Name Holding Percent Holding Id
Nishant Pradip Shah 1.1 74517115
HUF 0.98 74517107
Unclaimed or Suspense or Escrow Account 0.59 74517108
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Feb 16, 2024 2 INTERIM Feb 19, 2024 Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
Feb 07, 2024 Quarterly Results & Interim Dividend -
Nov 07, 2023 Quarterly Results -
Aug 05, 2023 Quarterly Results -
May 12, 2023 Audited Results -
Ex-Date Bonus Ratio Record Date
Bigul
04 May 2024

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Earnings Conference Call to discuss Company''s Q4-FY24/ FY24 Results.
Bigul
04 May 2024

Aarti Pharmalabs Ltd - 543748 - Board Meeting Intimation for Financial Results For The Quarter And Year Ended March 31, 2024 And Final Dividend For The Year Ended March 31, 2024

 Aarti Pharmalabs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2024 ,inter alia, to consider and approve Audited Financial Results for the quarter ended March 31, 2024; Audited Financial Statements for the year ended March 31, 2024; Recommend Final Dividend, if any, for the year ended March 31, 2024; Approve any other business matter, if required, with the permission of Chair.
Bigul
12 Apr 2024

Aarti Pharmalabs Ltd - 543748 - Certificate Pursuant To Regulation 40(9) Of The SEBI (LODR) Regulations, 2015

 Certificate pursuant to Regulation 40(9) of SEBI (LODR) Regulations, 2015 for the year ended March 31, 2024.
Bigul
04 Apr 2024

Aarti Pharmalabs Ltd - 543748 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018
Bigul
04 Apr 2024

Aarti Pharmalabs Ltd - 543748 - Compliance Certificate For The Financial Year Ended March 31, 2024

 Compliance Certificate pursuant to Regulation 7(3) of SEBI LODR Regulations.
Bigul
27 Mar 2024

Aarti Pharmalabs Ltd - 543748 - Closure of Trading Window

 Intimation of closure of trading window
20 Feb 2024

AARTIPHARM Consolidated December 2023 Net Sales at Rs 448.69 crore, down 69.27% Y-o-Y
Bigul
13 Feb 2024

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

 Transcript of Q3 FY24 Earnings conference call
Bigul
09 Feb 2024

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper Publication of Audited Financial Results for the quarter and nine months ended December 31, 2023
Bigul
08 Feb 2024

Aarti Pharmalabs Ltd - 543748 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

 Recording of Earnings Conference Call for Q3 / 9M FY24
See all News

FAQs

The latest market price of Aarti Pharmalabs Ltd. on NSE was Rs. 511.90 as of today.

The opening share price of Aarti Pharmalabs Ltd. was Rs. 510.00 as of today.

The 52-week high share price of Aarti Pharmalabs Ltd. was Rs. 567.00.

The 52 week low share price of Aarti Pharmalabs Ltd. was Rs. 320.30.

Aarti Pharmalabs Ltd. has a market cap of Rs. 4639.10 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Aarti Pharmalabs Ltd. is -0.70. Please refer to the Fundamentals section for further details.

The operating revenue for Aarti Pharmalabs Ltd. in the last FY was Rs.  1831.91 crore. Please refer to the Financials section for further details.

The Net Profit for Aarti Pharmalabs Ltd. in the last FY was Rs. 194.52 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Aarti Pharmalabs Ltd. was on 2024-02-16 for Rs. 2 per share. According to today’s share price, the dividend yield of Aarti Pharmalabs Ltd. stands at 0.40. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Aarti Pharmalabs Ltd..

Close

Let's Open Free Demat Account